A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Rutgers Health researchers have found that a weekly injection of diabetes medication could replace painful daily hormone shots for people with a rare genetic form of lipodystrophy that leaves patients ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

A recent survey found that more than half of people living with Type 1 diabetes say the condition has an impact on their ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

A recent survey found that more than half of adults living with Type 1 diabetes believe the condition limits their ability to be spontaneous ...

Insulin pumps and CGMS provide greater flexibility, improved blood sugar control, and better quality of life for children and ...